Brief: Pliant Therapeutics Inc - On February 17, 2023, Co Received Notice From Novartis Institutes For Biomedical Research, Inc.
Feb 23 (Reuters) - Pliant Therapeutics Inc PLRX.O :
* PLIANT THERAPEUTICS INC - ON FEBRUARY 17, 2023, CO
RECEIVED
NOTICE FROM NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
* PLIANT THERAPEUTICS -NOVARTIS HAS ELECTED TO EXERCISE
RIGHT TO
TERMINATE COLLABORATION & LICENSE AGREEMENT BETWEEN CO &
NOVARTIS, DATED OCT 17, 2019
* PLIANT THERAPEUTICS -TERMINATION OF COLLABORATION
AGREEMENT WILL
TAKE EFFECT ON APRIL 18, 2023
Source text for Eikon: ID:
Further company coverage: PLRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pliant Therapeutics
See all newsBrief: Pliant Therapeutics Announces Presentations At The 2026 Annual Meeting
Brief: Pliant Therapeutics Appoints David Raben, M.D., As Chief Medical Officer
RCS - Redx Pharma Limited - Redx Announces Final Audited Results
RCS - Redx Pharma Limited - Close of Series A; Strengthened Board Composition
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals